Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Thistle

What does the research say about Thistle?

5 health outcomes synthesised

Research on thistle (primarily in the form of silymarin) has been investigated across five health outcomes. The strongest evidence comes from liver enzyme reductions, with eight studies showing a large effect on aspartate aminotransferase (AST) levels in patients with liver conditions such as NAFLD and alcoholic liver disease. Doses ranging from 420 mg/day to 800 mg/day were used in these studies, with effects typically seen after 12 weeks or longer.

Strongest evidence: Moderate-strength evidence supports thistle for reducing liver enzymes. For aspartate aminotransferase (AST) , 5 of 8 studies reported a large beneficial effect in patients with liver conditions (NAFLD, ALD, hepatitis) and metabolic syndrome, with doses from 420 mg/day to 800 mg/day over at least 12 weeks. For alanine aminotransferase (ALT) , 4 of 6 studies found beneficial effects (small to large), with doses around 140 mg three times daily, typically after 15 weeks. For alkaline phosphatase (ALP) , all 3 studies showed small-to-moderate reductions, with doses of 140 mg daily after about 16 weeks.

Mixed or weaker evidence: Low-strength evidence exists for LDL cholesterol (3 of 3 studies beneficial, but small effect sizes and no consistent dose data) and triglycerides (2 of 3 studies beneficial, but effect sizes varied widely and one meta-analysis found a neutral result). The evidence base is small (3 studies each), so conclusions remain preliminary.

Effective dose patterns: When reported, the most common oral dose in studies was 140 mg three times daily (420 mg/day total), with a range up to 800 mg/day. Effects on liver enzymes were consistently observed after 12–16 weeks of supplementation, though many studies did not report specific dosing or product forms.

Population insights: The vast majority of evidence comes from clinical populations — patients with nonalcoholic fatty liver disease (NAFLD) , alcoholic liver disease (ALD) , hepatitis, and those at risk for drug-induced liver injury (e.g., on antituberculosis drugs). Benefit in healthy individuals is less established.

Notable caveats: Effect sizes varied widely across studies, from small to large, and 2–3 studies for each outcome found neutral results. Many studies had short durations and did not consistently report the dose, form (e.g., silymarin vs. silibinin), or duration. Publication bias is possible, as null results are less likely to be indexed. The evidence base for LDL and triglycerides is small and preliminary.

Frequently asked

  • What is thistle good for according to research?
    Research shows thistle (silymarin) can help reduce liver enzymes. The strongest evidence is for lowering AST (5 of 8 studies beneficial, moderate evidence) and ALT (4 of 6 studies beneficial, moderate evidence) in people with liver conditions such as NAFLD and alcoholic liver disease. Weaker evidence suggests possible small reductions in LDL cholesterol and triglycerides.
  • What dose of thistle is typically used in studies?
    The most commonly reported dose is 140 mg three times daily (420 mg/day total), though doses up to 800 mg/day have been studied. For ALP reduction, 140 mg daily was used. However, many studies did not consistently report dosing or specify the exact form (e.g., silymarin vs. silibinin), limiting precise dose recommendations.
  • Who benefits most from thistle?
    Research primarily shows benefits in clinical populations with liver conditions, such as NAFLD, alcoholic liver disease, hepatitis, and patients at risk for drug-induced liver injury (e.g., on antituberculosis drugs). Benefit in healthy individuals is less established, as most studies enrolled people with specific health conditions.
  • Are there caveats or limitations in the research on thistle?
    Yes. Effect sizes varied widely across studies, from small to large, and several studies found no significant effect. Many studies had short durations (around 12–16 weeks), did not report specific doses or product forms, and may be subject to publication bias. The evidence for LDL and triglycerides is based on only 3 studies each, so conclusions are preliminary.
  • Does thistle help reduce ALT (alanine aminotransferase) levels?
    Moderate evidence from 4 of 6 studies shows that thistle (silymarin) can reduce ALT levels, with effect sizes ranging from small to large. The two highest-quality meta-analyses found statistically significant reductions in patients with NAFLD and those on anti-TB drugs. Effects were typically observed after about 15 weeks of supplementation.
  • Is the evidence for thistle's effect on triglycerides reliable?
    The evidence is low and preliminary. Only 3 studies exist: 2 reported beneficial effects (with one large effect in alcoholic liver disease patients) and 1 found a neutral result. The only meta-analysis showed a non-significant effect. No consistent dose or form data are available, so these findings should be interpreted with caution.

Safety profile

12 studies reporting safety data1 increased-risk finding

In data from 12 clinical studies, thistle (silymarin/silibinin) was generally well tolerated, with most reports describing minimal or no adverse effects. One study reported an increased risk of adverse effects with silymarin use (RR 1.11–3.54), while the remaining 11 studies provided unquantified tolerability statements or mild event descriptions (e.g., gastrointestinal reactions, nausea, diarrhea, bloating, insomnia). No serious adverse events were flagged across any of the studies.

Caveats: Most studies were short-term and not specifically powered to detect rare adverse events; long-term safety data are limited. The increased risk finding comes from a single study, and the effect estimate's precision is uncertain.

Most-studied combinations with Thistle

most supplement research is combination research
Also studied with:Turmeric (4), Resveratrol (2), Red Grape (2), Berberine (3), Vitamin E (3), Turmeric (2), green tea (2)

  • Hyperdrive 4.0

    By ALR Industries

    5 (2 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $32.15
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out
Back to top